Lactoferrin inhibits growth of malignant tumors of the head and neck

ORL

Volumn 65, Issue 5, 2003, Pages 245-249

  Wolf, Jeffrey S ^a,b   Li, Daqing ^a   Taylor, Rodney J ^a   O'Malley Jr , Bert W ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Chemotherapy, head neck tumors; Fibrosarcoma; Lactoferrin; Squamous cell carcinoma

Indexed keywords

GLYCOPROTEIN; LACTOFERRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL LINE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; FIBROSARCOMA; GROWTH INHIBITION; HEAD TUMOR; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IN VITRO STUDY; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NECK TUMOR; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROSARCOMA; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOCOMPETENCE; INJECTIONS, INTRALESIONAL; LACTOFERRIN; MICE; MICE, INBRED C3H; MICE, NUDE; TUMOR CELLS, CULTURED;

EID: 1642578175     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075220     Document Type: Article

References (20)

1. Masson PL, et al: Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med 1969;130:643-658.
2. Baggiolini M, et al: Association of lactoferrin with specific granules in rabbit heterophil leukocytes. J Exp Med 1970;131:559-570.
3. Suzuki YA, Lonnerdal B: Characterization of mammalian receptors for lactoferrin. Biochem Cell Biol 2002;80:75-80.
4. Suzuki YA, et al: Molecular cloning and functional expression of a human intestinal lactoferrin receptor. Biochemistry 2001;40:15771-15779.
5. Cumberpatch M, et al: Regulation of epidermal Langerhans' cell migration by lactoferrin. Immunology 2000;100:21-28.
6. Guillen C, et al: Enhanced Th1 response to Staphylococcus aureus infection in human lactoferrin-transgenic mice. J Immunol 2002;168:3950-3957.
7. Mathur GP, et al: Breast-feeding and childhood cancer. Indian Pediatr 1993;30:651-657.
8. Hardell L, Dreifaldt AC: Breast-feeding duration and the risk of malignant diseases in childhood in Sweden. Eur J Clin Nutr 2001;55:179-185.
9. Iigo M, et al: Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin Exp Metastasis 1999;17:35-40.
10. Zucali JR, et al: Lactoferrin decreases monocyte-induced fibroblast production of myeloid colony-stimulating activity by suppressing monocyte release of interleukin-1. Blood 1989;74:1531-1536.
11. O'Malley BW Jr, et al: A new immunocompetent murine model for oral cancer. Arch Otolaryngol Head Neck Surg 1997;123:20-24.
12. Ushida Y, et al: Possible chemopreventive effects of bovine lactoferrin on esophagus and lung carcinogenesis. Jpn J Cancer Res 1999;90:262-267.
13. Wang WP, et al: Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin. Jpn J Cancer Res 2000;91:1022-1027.
14. Kuhara T, et al: Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium. Nutr Cancer 2000;38:192-199.
15. Bezault J, et al: Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res 1994;54:2310-2312.
16. 1 cyclin-dependent kinases during growth arrest of human breast carcinoma. J Cell Biochem 1999;74:486-498.
17. 1 cyclin-dependent kinases during growth arrest of head and neck cancer cells.
18. Chen Z, et al: Expression of proinflammatory and proangiogenic cytokines in human head and neck cancer. Clin Cancer Res 1999;5:1369-1379.
19. Ondrey FG, et al: Constitutive expression of proinflammatory cytokines and survival in head and neck squamous cell carcinoma cell lines. Mol Carcinog 1999;26:119-129.
20. Wolf JS, et al: IL (interleukin)-1α promotes nuclear factor-κB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clin Cancer Res 2001;7:1812-1820.